Express Pharma

Lupin gets FDA nod to market generic antibiotic medicine in US

Doxycyline capsule is a generic equivalent of Galderma Laboratories' Oracea capsules

1 222

Lupin recently said it has received approval from the US health regulator to market Doxycycline capsules used to treat bacterial infections in the American market, Lupin said in a statement.

The drug firm has received tentative approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Doxycycline capsules, 40 mg, a generic equivalent of Galderma Laboratories’ Oracea capsules, the statement added.

Edits by EP News Bureau

- Advertisement -